Clinuvel Pharmaceuticals (Australia) Today
| CUV Stock | 14.99 0.10 0.67% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Clinuvel Pharmaceuticals is selling for under 14.99 as of the 28th of April 2024; that is 0.67% increase since the beginning of the trading day. The stock's last reported lowest price was 14.95. Clinuvel Pharmaceuticals has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Clinuvel Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of March 2024 and ending today, the 28th of April 2024. Click here to learn more.
Moving against Clinuvel Stock
| 0.48 | CBAPG | Commonwealth Bank | PairCorr |
| 0.47 | CBA | Commonwealth Bank | PairCorr |
| 0.46 | CBAPH | Commonwealth Bank | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Clinuvel Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Clinuvel Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Clinuvel Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| MD CEO | MD MBA |
| Business Concentration | Health Care, Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
Clinuvel Pharmaceuticals (CUV) is traded on Australian Securities Exchange in Australia and employs 9 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 751.41 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Clinuvel Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Clinuvel Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Clinuvel Pharmaceuticals operates under Biotechnology sector and is part of Health Care industry. The entity has 50.13 M outstanding shares.
Clinuvel Pharmaceuticals generates positive cash flow from operations, but has no cash available
Check Clinuvel Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationClinuvel Pharmaceuticals holds a total of 50.13 Million outstanding shares. Clinuvel Pharmaceuticals retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Clinuvel Ownership Details
Clinuvel Pharmaceuticals Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Clinuvel Pharmaceuticals market risk premium is the additional return an investor will receive from holding Clinuvel Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Clinuvel Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Clinuvel Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Clinuvel Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.15 | |||
| Semi Deviation | 2.98 | |||
| Standard Deviation | 3.3 | |||
| Variance | 10.88 |
Clinuvel Stock Against Markets
Picking the right benchmark for Clinuvel Pharmaceuticals stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Clinuvel Pharmaceuticals stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Clinuvel Pharmaceuticals is critical whether you are bullish or bearish towards Clinuvel Pharmaceuticals at a given time. Please also check how Clinuvel Pharmaceuticals' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Clinuvel Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
| All Next | Launch Module |
Clinuvel Pharmaceuticals Corporate Management
Elected by the shareholders, the Clinuvel Pharmaceuticals' board of directors comprises two types of representatives: Clinuvel Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Clinuvel. The board's role is to monitor Clinuvel Pharmaceuticals' management team and ensure that shareholders' interests are well served. Clinuvel Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Clinuvel Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lachlan Hay | Director Operations | Profile | |
| Malcolm Bull | Head Relations | Profile | |
| Azza Hamila | Head Safety | Profile | |
| Darren Keamy | CFO Sec | Profile | |
| MBA MD | MD CEO | Profile |
How to buy Clinuvel Stock?
Before investing in Clinuvel Pharmaceuticals, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Clinuvel Pharmaceuticals. To buy Clinuvel Pharmaceuticals stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Clinuvel Pharmaceuticals. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Clinuvel Pharmaceuticals stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Clinuvel Pharmaceuticals stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Clinuvel Pharmaceuticals stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Clinuvel Pharmaceuticals, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Clinuvel Pharmaceuticals?
The danger of trading Clinuvel Pharmaceuticals is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Clinuvel Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Clinuvel Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Clinuvel Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clinuvel Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for Clinuvel Stock analysis
When running Clinuvel Pharmaceuticals' price analysis, check to measure Clinuvel Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clinuvel Pharmaceuticals is operating at the current time. Most of Clinuvel Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Clinuvel Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clinuvel Pharmaceuticals' price. Additionally, you may evaluate how the addition of Clinuvel Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |